AVNRT epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
{{CMG}}; {{AE}} {{RG}}
{{CMG}}; {{AE}} {{RG}}
==Overview==
==Overview==
 
AVNRT is mor dominant in lower age and is more related to female gender.
==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence===
===Incidence===
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
*The incidence of AVNRT is approximately 89,000 in US annually.<re name="Electrophysiology : the basics">{{cite book|last=Steinberg|first=Jonathan|title=Electrophysiology : the basics|publisher=Wolters Kluwer Heath|location=Philadelphia|year=2017|isbn=9781496340016}}</ref>
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.


===Prevalence===
===Prevalence===
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
*The prevalence of AVNRT is approximately 570,000 per US population
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
 
===Case-fatality rate/Mortality rate===
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
*The case-fatality rate/mortality rate of [disease name] is approximately [number range].


===Age===
===Age===
*Patients of all age groups may develop [disease name].
*Mean age of symptom onset is 32 ± 18 years.<ref name="QuattrocelliLang2018">{{cite journal|last1=Quattrocelli|first1=Amanda|last2=Lang|first2=Janet|last3=Davis|first3=Andrew|last4=Pflaumer|first4=Andreas|title=Age makes a difference: Symptoms in pediatric supraventricular tachycardia|journal=Journal of Arrhythmia|volume=34|issue=5|year=2018|pages=565–571|issn=1880-4276|doi=10.1002/joa3.12103}}</ref>
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.  
*[Chronic disease name] is usually first diagnosed among [age group].
*[Acute disease name] commonly affects [age group].


===Race===
===Race===
*There is no racial predilection to [disease name].
*There is no racial predilection to AVNRT.
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
 
===Gender===
===Gender===
*[Disease name] affects men and women equally.
*AVNRT affects women more than men.
*[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.


===Region===
===Region===
*The majority of [disease name] cases are reported in [geographical region].
*The prevalence of AVNRT globally is similar to the united states.
 
*There is no article suggesting a region being more vulnerable to disease.
*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
 
===Developed Countries===
 
===Developing Countries===


==References==
==References==

Revision as of 15:39, 13 April 2020

AVNRT Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating AVNRT from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diaagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Overview

Medical Treatment

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Case Studies

Case #1

AVNRT epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of AVNRT epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on AVNRT epidemiology and demographics

CDC on AVNRT epidemiology and demographics

AVNRT epidemiology and demographics in the news

Blogs on AVNRT epidemiology and demographics

Directions to Hospitals Treating AVNRT

Risk calculators and risk factors for AVNRT epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]

Overview

AVNRT is mor dominant in lower age and is more related to female gender.

Epidemiology and Demographics

Incidence

  • The incidence of AVNRT is approximately 89,000 in US annually.<re name="Electrophysiology : the basics">Steinberg, Jonathan (2017). Electrophysiology : the basics. Philadelphia: Wolters Kluwer Heath. ISBN 9781496340016.</ref>

Prevalence

  • The prevalence of AVNRT is approximately 570,000 per US population

Age

  • Mean age of symptom onset is 32 ± 18 years.[1]

Race

  • There is no racial predilection to AVNRT.

Gender

  • AVNRT affects women more than men.

Region

  • The prevalence of AVNRT globally is similar to the united states.
  • There is no article suggesting a region being more vulnerable to disease.

References

  1. Quattrocelli, Amanda; Lang, Janet; Davis, Andrew; Pflaumer, Andreas (2018). "Age makes a difference: Symptoms in pediatric supraventricular tachycardia". Journal of Arrhythmia. 34 (5): 565–571. doi:10.1002/joa3.12103. ISSN 1880-4276.

Template:WH Template:WS